phase 2_completion
saveShanghai Longfine Biotechnology Co Ltd — toripalimab (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Triple-Negative Breast Cancer (TNBC)